Jerini AG to Wind Down its Preclinical Programs

29-Jun-2009 - Germany

Jerini AG has decided to end all negotiations regarding the transfer of assets associated with Jerini AG's preclinical programs and to terminate the employees associated with these programs. The decision was taken following unsuccessful efforts to find an investor for the sale of the preclinical programs. The redundancies reduce Jerini AG's head-count by more than 45.

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance